The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy☆
To access this article, please choose from the options below
☆ Address reprint requests to James V. Donadio, MD, Mayo Nephrology Collaborative Group, Mayo Clinic & Foundation, 200 First St, SW, MNCG Study Desk Eisenberg-S24, Rochester, MN 55905.
PII: S1051-2276(01)70024-6
© 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

